As a retired IT specialist, William April has an insider’s understanding of computer security. And for the past six years, he has taken that expertise—along with his big smile and booming voice—on the road for AARP Vermont, delivering fraud prevention presentations to groups across the state.
AARP Vermont is pleased to announce that William (Bill) April has been selected as the recipient of the 2024 Andrus Award for Community Service, the organization’s most prestigious and visible volunteer award. This award recognizes outstanding community service and is named after AARP’s founder, Dr. Ethel Percy Andrus.
Almost half the people who work for private businesses in the state do not have a retirement savings plan through their employer, according to a 2015 AARP study.
Would you like to see a park located near the new Transit Center in Montpelier that provides connectivity to the bike path and access to the river? If so, please join VT River Conservancy (VRC) & AARP VT on Tuesday, December 4th to hear about the Confluence River Park in the heart of downtown Montpelier. This park will be located on the One Taylor Street parcel, at the confluence of the North Branch and main stems of the Winooski River. VRC has contracted with an engineering and design firm to create a Conceptual Design for the park. Come hear about the process and timeline, offer input to make this park age-friendly by sharing your priorities for a Confluence River Park. What would you like to see at a Montpelier riverside park? How would you use it? We want to hear from you!
AARP Vermont is presenting its most prestigious award for community service to Linda Bowden, a lead volunteer for livable communities and an advisory council member.
About 40,000 taxpayers who rely on Social Security will no longer pay state taxes on those benefits, thanks to the advocacy of AARP and its volunteers.
Retail prices for many of the most commonly-used brand name drugs by older adults rocketed upward by an average of 8.4 percent in 2017, outstripping the general inflation rate of 2.1 percent. The annual average cost of therapy for just one brand name drug increased to almost $6,800 in 2017.